0,681  0,004  Antineoplastic (bladder cancer)
0,696  0,024  Caspase 9 stimulant
0,666  0,005  Antineoplastic (glioma)
0,608  0,005  Antineoplastic (glioblastoma multiforme)
0,611  0,012  Antineoplastic (melanoma)
0,611  0,017  Antiprotozoal
0,604  0,012  Antiprotozoal (Plasmodium)
0,560  0,018  Aryl hydrocarbon receptor agonist
0,544  0,016  GABA C receptor rho-3 antagonist
0,517  0,012  DNA damaging
0,524  0,032  Antineoplastic (colorectal cancer)
0,503  0,019  Antineoplastic (brain cancer)
0,509  0,032  Antineoplastic (colon cancer)
0,478  0,011  Antineoplastic (renal cancer)
0,475  0,018  CYP1A2 inhibitor
0,464  0,022  Antineoplastic (non-small cell lung cancer)
0,446  0,006  DNA intercalator
0,458  0,026  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,484  0,058  Antineoplastic (breast cancer)
0,472  0,048  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,470  0,045  Antileukemic
0,456  0,033  Antineoplastic (ovarian cancer)
0,467  0,051  Antineoplastic (lung cancer)
0,491  0,077  Apoptosis agonist
0,426  0,013  Antineoplastic (sarcoma)
0,423  0,025  Hypoxia-inducible factor 1 alpha inhibitor
0,435  0,039  Streptokinase A inhibitor
0,439  0,044  Prostate cancer treatment
0,428  0,033  Antimycobacterial
0,418  0,028  Mutagenic
0,399  0,025  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,421  0,052  CYP2C19 inhibitor
0,393  0,030  Radiosensitizer
0,364  0,012  Topoisomerase II inhibitor
0,379  0,030  Dyrk kinase inhibitor
0,379  0,032  Antiprotozoal (Trypanosoma)
0,372  0,027  Pyruvate kinase inhibitor
0,353  0,015  Carcinogenic, group 3
0,359  0,027  Peroxidase inhibitor
0,382  0,051  FMO1 substrate
0,334  0,005  Porphobilinogen synthase inhibitor
0,364  0,041  Calcium channel activator
0,346  0,024  RNA-directed DNA polymerase inhibitor
0,328  0,008  Cystathionine beta-synthase inhibitor
0,317  0,004  CYP2A6 inhibitor
0,361  0,048  CYP1A2 substrate
0,348  0,035  Antineoplastic (small cell lung cancer)
0,323  0,011  Heat shock protein 90 alpha antagonist
0,336  0,029  GST M1-1 substrate
0,313  0,009  Heat shock protein 90 antagonist
0,349  0,046  Antineoplastic (cervical cancer)
0,318  0,016  Antineoplastic (gastric cancer)
0,315  0,015  UGT2B15 substrate
0,385  0,088  5 Hydroxytryptamine release inhibitor
0,372  0,078  GST A substrate
0,310  0,016  CYP2B6 inhibitor
0,342  0,049  Antituberculosic
0,383  0,093  Calcium channel L-type activator
0,361  0,077  CYP2C9 substrate
0,344  0,061  Caspase 3 stimulant
0,298  0,023  Pneumotoxic
0,331  0,057  Antineoplastic (pancreatic cancer)
0,289  0,018  Genotoxic
0,346  0,080  CYP3A4 substrate
0,323  0,063  5 Hydroxytryptamine release stimulant
0,269  0,009  Topoisomerase II alpha inhibitor
0,302  0,044  UGT1A6 substrate
0,309  0,058  UGT1A9 substrate
0,270  0,021  Nitric-oxide synthase stimulant
0,251  0,006  NAT2 substrate
0,254  0,011  GABA C receptor rho-2 antagonist
0,253  0,012  Phobic disorders treatment
0,296  0,058  Transcription factor STAT inhibitor
0,249  0,012  Mannose-6-phosphate isomerase inhibitor
0,284  0,049  Antineoplastic (lymphocytic leukemia)
0,257  0,025  MAP kinase kinase 3 inhibitor
0,336  0,106  Histamine release inhibitor
0,283  0,054  Cytotoxic
0,338  0,109  Antibacterial
0,232  0,005  NAT1 substrate
0,333  0,106  MAP kinase kinase 6 inhibitor
0,296  0,074  CTGF expression inhibitor
0,306  0,086  ICAM1 expression inhibitor
0,246  0,027  NOS3 expression enhancer
0,278  0,061  Sensitization
0,276  0,061  Cardiovascular analeptic
0,237  0,024  Aldehyde oxidase substrate
0,324  0,115  15-Lipoxygenase inhibitor
0,283  0,077  Antineoplastic (multiple myeloma)
0,273  0,068  Transcription factor STAT3 inhibitor
0,310  0,108  CYP2C9 inhibitor
0,218  0,022  Topoisomerase I inhibitor
0,239  0,044  LIM domain kinase 1 inhibitor
0,240  0,047  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,209  0,016  Antiprotozoal (Amoeba)
0,219  0,026  Hexokinase inhibitor
0,208  0,016  Movement disorders treatment
0,233  0,046  UGT1A4 substrate
0,210  0,026  GST P1-1 substrate
0,191  0,008  T cell inhibitor
0,277  0,094  12-Lipoxygenase inhibitor
0,205  0,025  Alkylator
0,218  0,039  Antineoplastic (carcinoma)
0,222  0,045  Age-related macular degeneration treatment
0,260  0,083  UGT2B4 substrate
0,198  0,021  Antiprotozoal (Trichomonas)
0,233  0,057  Antiviral (West Nile virus)
0,303  0,128  TNF expression inhibitor
0,247  0,073  Antineoplastic (liver cancer)
0,179  0,006  Acetylcholine release stimulant
0,253  0,081  Aldehyde oxidase inhibitor
0,183  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,191  0,021  Interleukin 1b antagonist
0,228  0,061  Carcinogenic
0,179  0,011  Myasthenia Gravis treatment
0,228  0,061  VCAM1 expression inhibitor
0,203  0,037  Antiseptic
0,244  0,078  Superoxide dismutase inhibitor
0,259  0,094  Lipoxygenase inhibitor
0,242  0,078  Tumour necrosis factor alpha release inhibitor
0,237  0,076  DNA synthesis inhibitor
0,210  0,050  Mcl-1 antagonist
0,219  0,060  Neurotrophic factor enhancer
0,188  0,030  CF transmembrane conductance regulator agonist
0,198  0,042  Glycogen synthase kinase-3 alpha inhibitor
0,269  0,114  Transcription factor NF kappa B inhibitor
0,190  0,037  Interleukin 1 antagonist
0,233  0,086  Tyrosine 3 hydroxylase inhibitor
0,175  0,028  Carcinogenic, group 2B
0,216  0,070  Amyloid beta aggregation inhibitor
0,219  0,075  Antiparasitic
0,209  0,066  UGT1A1 substrate
0,279  0,136  Antipruritic, allergic
0,237  0,096  Gastrin inhibitor
0,246  0,105  FMO3 substrate
0,151  0,010  Alcohol oxidase inhibitor
0,314  0,175  Antineoplastic (solid tumors)
0,221  0,082  Cytostatic
0,205  0,068  Abortion inducer
0,241  0,107  Antihypoxic
0,155  0,021  Arylamine N-Acetyltransferase substrate
0,178  0,044  Antiprotozoal (Coccidial)
0,153  0,019  Alcohol dehydrogenase inhibitor
0,159  0,026  Photosensitizer
0,263  0,131  Ulceration
0,232  0,100  Chemoprotective
0,183  0,052  UGT2B10 substrate
0,164  0,033  Cyclin-dependent kinase 5 inhibitor
0,139  0,008  CDC25B inhibitor
0,238  0,108  Respiratory analeptic
0,162  0,032  Coagulant
0,199  0,071  Histone acetyltransferase inhibitor
0,194  0,066  VEGF expression inhibitor
0,149  0,022  GABA C receptor rho-1 antagonist
0,196  0,070  5 Hydroxytryptamine 3E antagonist
0,170  0,044  Antianemic
0,157  0,032  GABA receptor agonist
0,154  0,034  Ca2+-transporting ATPase inhibitor
0,216  0,096  Antipyretic
0,159  0,039  MAO A inhibitor
0,182  0,061  UGT1A3 substrate
0,161  0,041  Aldehyde dehydrogenase inhibitor
0,126  0,006  Topoisomerase II beta inhibitor
0,242  0,123  CYP3A4 inhibitor
0,132  0,015  Phenylalanine 4-hydroxylase inhibitor
0,210  0,094  Antiprotozoal (Leishmania)
0,126  0,013  HIV-1 integrase inhibitor
0,136  0,023  Telomerase inhibitor
0,131  0,018  Cyclin B3 inhibitor
0,147  0,036  Sphingosine 1-phosphate receptor 4 antagonist
0,147  0,036  Antiprotozoal (Babesia)
0,223  0,113  5 Hydroxytryptamine uptake stimulant
0,237  0,128  AR expression inhibitor
0,161  0,054  Cytokine production inhibitor
0,130  0,023  Histamine N-methyltransferase inhibitor
0,204  0,099  NOS2 expression inhibitor
0,141  0,037  CC chemokine 6 receptor antagonist
0,113  0,008  Heat shock protein 90 beta antagonist
0,168  0,064  Neuropathy treatment
0,163  0,061  Antidote
0,130  0,030  Carcinogenic, group 2A
0,136  0,035  Antifungal (Pneumocystis)
0,122  0,023  GABA A receptor agonist
0,178  0,080  CDC-like kinase 4 inhibitor
0,131  0,034  Creatine kinase inhibitor
0,123  0,026  Antidote, mercury
0,138  0,042  SULT1A1 substrate
0,150  0,053  Pregnane X receptor agonist
0,133  0,038  Mediator release inhibitor
0,127  0,032  Mental retardation treatment
0,134  0,040  GABA C receptor antagonist
0,180  0,087  Non-steroidal antiinflammatory agent
0,144  0,052  Antibacterial (Helicobacter pylori)
0,150  0,058  Antifungal (Cryptococcus)
0,154  0,063  Antineoplastic (squamous cell carcinoma)
0,101  0,010  Glutamate (mGluR7) antagonist
0,111  0,022  Granulocyte macrophage colony stimulating factor agonist
0,208  0,119  Flavin-containing monooxygenase substrate
0,191  0,102  Antineoplastic (lymphoma)
0,162  0,074  Arachidonic acid antagonist
0,151  0,063  SULT1A3 substrate
0,099  0,011  Dihydroorotate dehydrogenase inhibitor
0,158  0,071  Carcinogenic, group 1
0,218  0,132  CYP2D6 inhibitor
0,125  0,039  Gastric antisecretory
0,228  0,143  Antineoplastic (osteosarcoma)
0,125  0,040  Dementia treatment
0,131  0,047  Antiviral (Influenza B)
0,169  0,086  Antirickettsial
0,099  0,016  Antidote, organophosphates
0,092  0,009  Transcription factor RelA inhibitor
0,150  0,068  Hemostatic
0,117  0,036  Estrogen receptor beta antagonist
0,120  0,039  Vascular dementia treatment
0,251  0,171  Antineoplastic (myeloid leukemia)
0,132  0,052  DNA repair enzyme inhibitor
0,150  0,072  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,165  0,087  Antineoplastic (bone cancer)
0,162  0,084  3C-like protease (Human coronavirus) inhibitor
0,088  0,011  H+/K+-transporting ATPase inhibitor
0,200  0,124  Proliferative diseases treatment
0,149  0,073  Acaricide
0,146  0,070  Activin receptor-like kinase 2 inhibitor
0,206  0,130  Analeptic
0,102  0,027  CDC25A inhibitor
0,129  0,057  Contraceptive female
0,139  0,067  Nav1.6 sodium channel blocker
0,102  0,030  Phosphodiesterase XI inhibitor
0,102  0,030  Phosphodiesterase 11A inhibitor
0,122  0,051  Estrogen antagonist
0,123  0,051  Gout treatment
0,234  0,162  Immunosuppressant
0,211  0,140  Insulysin inhibitor
0,134  0,064  Antihemorrhagic
0,157  0,087  Dual specificity phosphatase inhibitor
0,164  0,094  Antihelmintic
0,084  0,014  Andropause treatment
0,108  0,038  Antithrombocytopenic
0,117  0,047  CDC-like kinase 3 inhibitor
0,094  0,025  HIV-1 integrase (Strand Transfer) inhibitor
0,092  0,023  Aromatase inhibitor
0,136  0,067  MAO inhibitor
0,117  0,049  Antiprotozoal (Toxoplasma)
0,085  0,016  Fatty acid synthase inhibitor
0,103  0,035  Xanthine oxidase substrate
0,146  0,078  Antimutagenic
0,082  0,015  Corticotropin releasing factor 2 receptor antagonist
0,090  0,023  S-adenosyl-L-methionine decarboxylase inhibitor
0,144  0,079  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,084  0,019  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,154  0,090  CDC-like kinase 2 inhibitor
0,110  0,045  MAP kinase kinase 1 inhibitor
0,157  0,093  Antipruritic, non-allergic
0,076  0,012  Mineralocorticoid receptor antagonist
0,215  0,152  Cholesterol antagonist
0,124  0,062  Cholesterol synthesis inhibitor
0,112  0,051  GST T1-1 substrate
0,163  0,103  Clk dual-specificity kinase inhibitor
0,167  0,107  Growth factor agonist
0,270  0,212  MAP kinase 1 inhibitor
0,116  0,058  Excitatory amino acid transporter EAAC1 inhibitor
0,115  0,057  Ferrochelatase inhibitor
0,175  0,118  Antiamyloidogenic
0,070  0,014  Pregnane X receptor antagonist
0,081  0,025  Aryl hydrocarbon receptor antagonist
0,156  0,102  Succinate dehydrogenase inhibitor
0,104  0,050  Lanosterol 14 alpha demethylase inhibitor
0,064  0,010  Glucocorticoid antagonist
0,118  0,065  Menstruation disorders treatment
0,171  0,118  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,084  0,032  HIV-1 integrase (3'-Processing) inhibitor
0,139  0,087  MAP kinase kinase 4 inhibitor
0,205  0,153  Prostaglandin dehydrogenase inhibitor
0,162  0,110  MAP kinase kinase 2 inhibitor
0,080  0,028  Potassium channel (ATP-sensitive) blocker
0,095  0,044  Antileprosy
0,143  0,092  UGT2B7 substrate
0,073  0,023  Potassium channel intermediate-conductance Ca-activated blocker
0,105  0,055  UDP-glucose 4-epimerase inhibitor
0,171  0,121  Cyclic AMP phosphodiesterase inhibitor
0,149  0,099  Cyclin-dependent kinase 3 inhibitor
0,096  0,046  Bromodomain-containing protein 2 inhibitor
0,110  0,061  Glutathione S-transferase substrate
0,198  0,150  Antifungal
0,077  0,030  Exportin-1 inhibitor
0,089  0,042  Caspase 7 inhibitor
0,067  0,020  Aconitate hydratase inhibitor
0,205  0,159  Antiallergic
0,101  0,056  Antineoplastic, alkylator
0,095  0,050  Glutamate release inhibitor
0,104  0,059  Sulfotransferase substrate
0,070  0,025  Botulinum neurotoxin type A inhibitor
0,136  0,092  Eye irritation, high
0,114  0,070  Shock treatment
0,138  0,095  Interferon gamma antagonist
0,094  0,052  Antineoplastic alkaloid
0,136  0,094  Heat shock protein 70 antagonist
0,169  0,128  Antiviral (Ebola)
0,123  0,083  Alkaline phosphatase inhibitor
0,126  0,086  Protein kinase (CK1) inhibitor
0,103  0,064  GABA C receptor agonist
0,119  0,079  Acetylcholinesterase inhibitor
0,083  0,044  Estrogen receptor alpha antagonist
0,098  0,059  Antifungal (Candida)
0,054  0,017  Guanylate cyclase inhibitor
0,069  0,032  Xanthine dehydrogenase inhibitor
0,104  0,068  Antihelmintic (Fasciola)
0,112  0,076  Transcription factor STAT6 inhibitor
0,097  0,062  Xanthine oxidase inhibitor
0,067  0,033  Cyclin D1 inhibitor
0,041  0,007  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,130  0,097  Thiol protease inhibitor
0,045  0,013  Vanilloid 3 antagonist
0,062  0,030  Cyclin B2 inhibitor
0,061  0,029  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,118  0,087  Antihelmintic (Trematoda)
0,142  0,111  Tumour necrosis factor antagonist
0,085  0,055  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,067  0,037  Antiviral (Parainfluenza)
0,149  0,120  I kappa B kinase epsilon inhibitor
0,115  0,085  Tubulin antagonist
0,140  0,112  Hearing loss treatment
0,102  0,073  5 Hydroxytryptamine 3A agonist
0,042  0,014  Free fatty acid receptor 1 antagonist
0,174  0,146  Antihypotensive
0,095  0,067  UGT2B11 substrate
0,106  0,078  TRPA1 agonist
0,094  0,066  Butyrylcholinesterase inhibitor
0,146  0,118  Anesthetic general
0,085  0,057  mTOR complex 2 inhibitor
0,150  0,123  Death-associated protein kinase 3 inhibitor
0,102  0,075  Chelator
0,047  0,021  Urate transporter 1 inhibitor
0,092  0,066  Obsessive-compulsive disorder treatment
0,048  0,023  Glutamate (mGluR group III) antagonist
0,054  0,029  CD45 antagonist
0,051  0,028  Aldosterone antagonist
0,098  0,075  UGT2B1 substrate
0,145  0,122  DNA methylase inhibitor
0,108  0,086  MAP kinase 12 inhibitor
0,049  0,027  Benzodiazepine inverse agonist
0,102  0,081  Nav1.5 sodium channel blocker
0,118  0,096  Lipid peroxidase inhibitor
0,083  0,061  D-Ala-D-Ala ligase inhibitor
0,226  0,204  Transcription factor inhibitor
0,124  0,103  Cholinergic
0,086  0,065  Triose-phosphate isomerase inhibitor
0,033  0,012  Methionyl aminopeptidase 2 inhibitor
0,093  0,073  Anabolic
0,110  0,090  Cathepsin H inhibitor
0,071  0,052  Orexin receptor 1 antagonist
0,061  0,042  TRPA1 antagonist
0,060  0,042  Alpha 2 adrenoreceptor agonist
0,098  0,081  Protein kinase C gamma inhibitor
0,124  0,107  MAP3K9 inhibitor
0,116  0,099  CDC-like kinase 1 inhibitor
0,044  0,028  GABA B receptor antagonist
0,081  0,065  Androgen antagonist
0,084  0,068  Proto-oncogene tyrosine-protein kinase Kit inhibitor
0,024  0,009  Progesterone agonist
0,042  0,027  Hypogonadism treatment
0,039  0,024  Antiviral (Bovine viral diarrhea virus)
0,093  0,078  Carbonic anhydrase XV inhibitor
0,138  0,123  ATPase inhibitor
0,093  0,078  Skin irritative effect
0,022  0,008  Alpha 2b adrenoreceptor agonist
0,085  0,071  Thioredoxin inhibitor
0,044  0,030  Geranyltranstransferase inhibitor
0,088  0,074  Posttraumatic stress disorder treatment
0,154  0,140  Free radical scavenger
0,034  0,021  Calcium release-activated channel blocker
0,113  0,100  Antianorexic
0,110  0,097  Toll-Like receptor 9 antagonist
0,039  0,026  Alpha 1d adrenoreceptor agonist
0,125  0,113  Adenylate cyclase stimulant
0,036  0,023  Retinoid X alpha receptor agonist
0,053  0,041  Cyclin B inhibitor
0,124  0,113  UGT2B9 substrate
0,082  0,071  NADH dehydrogenase inhibitor
0,020  0,010  Alpha 2c adrenoreceptor agonist
0,148  0,139  Antiparkinsonian, rigidity relieving
0,082  0,073  Pim-3 kinase inhibitor
0,037  0,028  Potassium channel Kv1.1 blocker
0,019  0,010  Alpha 2a adrenoreceptor agonist
0,044  0,035  Glutamate (mGluR5) agonist
0,039  0,031  Acid-sensing ion channel blocker
0,021  0,013  Imidazoline I1 receptor antagonist
0,042  0,034  Glutamate (mGluR4) antagonist
0,053  0,046  5 Hydroxytryptamine 7 agonist
0,066  0,059  MAP kinase 11 inhibitor
0,081  0,075  MAO B inhibitor
0,113  0,107  Antineoplastic (uterine cancer)
0,027  0,021  Glucosylceramidase stimulant
0,097  0,091  Activin receptor-like kinase 4 inhibitor
0,116  0,110  Chemopreventive
0,084  0,079  Anticataract
0,050  0,046  Bromodomain-containing protein 4 inhibitor
0,048  0,044  Alpha tubulin antagonist
0,028  0,024  Purinergic P2Y14 antagonist
0,055  0,050  Cyclin B1 inhibitor
0,090  0,087  Beta glucuronidase inhibitor
0,064  0,061  Benzodiazepine agonist
0,039  0,036  Angiotensin AT1 receptor antagonist
0,064  0,061  MAP kinase 14 inhibitor
0,098  0,095  Microtubule formation inhibitor
0,016  0,014  CC chemokine 9 receptor antagonist
0,011  0,008  Imidazoline I2 receptor antagonist
0,014  0,011  Egl nine homolog 1 inhibitor
0,138  0,135  Neurotensin receptor agonist
0,030  0,029  Antihyperaldosteronism
0,018  0,016  Granulocyte colony stimulating factor receptor agonist
0,064  0,063  Glutamate decarboxylase inhibitor
0,080  0,079  Actinic keratosis treatment
0,051  0,050  Postcoital contraceptive
0,040  0,040  Histamine H1 receptor agonist
0,068  0,068  Fibroblast growth factor 3 antagonist
0,094  0,094  Antifungal (Aspergillus)

